Gastritis
Voquezna back on track with FDA approval for erosive esophagitis, heartburn relief
The FDA has approved Phathom Pharmaceuticals’ Voquezna tablets 10 mg and 20 mg to treat erosive esophagitis, or erosive gastroesophageal reflux disease, and alleviate heartburn associated with the disease, noted a company release.
Benralizumab induces remission in 77% of patients with eosinophilic gastritis
Benralizumab induced histological remission at 12 weeks in more than three-fourths of patients with eosinophilic gastritis, although other biomarkers of disease persisted, according to data in The Lancet Gastroenterology & Hepatology.
1-year surveillance endoscopy recommended for patients at high risk for gastric cancer
Patients at high risk for gastric cancer should undergo 1-year surveillance endoscopy, regardless of whether they initially underwent intensive index endoscopic examination using white light and narrow-band imaging, according to a study.
AGA expert review updates clinical practice on diagnosis of atrophic gastritis
Lirentelimab safe, effective in long-term gastritis, duodenitis treatment
Lirentelimab was safe and effective in the long-term treatment of patients with eosinophilic gastritis and/or eosinophilic duodenitis, according to a presentation at UEG Week.
Steroids ‘one of the more vexing treatment modalities’ in pediatrics
In a presentation during the virtual Infectious Diseases in Children Symposium, C. Buddy Creech, MD, MPH, called steroids “one of the more vexing treatment modalities in pediatrics.”